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ABSTRACT OF THESIS 
 
 
 
 
MAGNETIC RESONANCE IMAGING OF THE HUMAN INFERIOR VENA CAVA 
DURING LOWER BODY NEGATIVE PRESSURE 
 
 
Magnetic Resonance Imaging (MRI) was used to determine changes in the size of the 
Inferior Vena Cava (IVC) as a result of blood pooling induced by lower body negative 
pressure (LBNP).  Images of the IVC of supine human subjects (10 males, 10 females) 
were obtained under four conditions: 1) steady-state 0 mmHg LBNP, 2) steady-state –
35 mmHg LBNP, 3) ramping from 0 to –35 mmHg LBNP, 4) ramping from –35 to 0 
mmHg LBNP.  Volumes for a given IVC segment were obtained under the first two 
conditions during both end inspiration and end expiration breath-holds.  Inferior Vena 
Cava widths were measured under all four conditions at the levels of portal entry and 
portal exit.  The IVC volume for men and women combined decreased 41% due to 
LBNP (p < 1.02 x 10-9).  The IVC was 64.4% wider at portal exit than at portal entry in 
men (p < 0.0003).  Lower Body Negative Pressure induced a decrease in men’s vena 
cava width up to 46% at portal exit and up to 62% at portal entry.  Supported by NASA 
EPSCoR WKU 522611 and NIH GCRC MO1 RR262. 
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1 Introduction 
Orthostatic intolerance is a condition characterized by the cardiovascular 
system’s inability to adjust to stresses that impede return of blood to the heart and 
delivery to the brain.  Challenges can be as common as moving from a sitting or supine 
position to a standing one.  Symptoms of orthostatic stress can be as minor as a “head 
rush” or as problematic as a condition called “syncope.”  Syncope is characterized by a 
loss of consciousness resulting from insufficient cerebral perfusion; this end result is a 
consequence of the cardiovascular system’s failure to regulate blood pressure and 
blood flow [1]. 
Syncope affects a wide range of people.  Astronauts face a significant risk of 
syncope as a result of prolonged weightlessness [2].  Spinal cord trauma victims often 
have difficulty regulating against orthostatic stresses during diagnostic and therapeutic 
procedures that use tilt tables [3].  Many otherwise healthy people also suffer from 
syncope of unexplained origin. 
Given current plans to conduct manned missions to Mars, the risk of syncope in 
astronauts is of particular interest to NASA and partner space programs.  Given current 
technology, a trip to Mars will take months, exposing astronauts to a weightless 
environment for a very long time before descending into Mars’ gravitational pull [4].  
Because prolonged weightlessness has been shown to increase the risk of syncope in 
astronauts, effective countermeasures are critical to preventing them from succumbing 
to orthostatic stress far from medical care. 
On Earth, six to seven percent of the elderly (60+ years of age) experience 
syncope annually with 30 percent recurrence within one year of their initial episode.  
Syncope accounts for three percent of all emergency room visits and up to six percent 
of general hospital medical admissions, costing roughly $750 million to diagnose and 
treat.  Unexplained syncope, cases in which the root cause of the stress is unknown, 
accounts for fifty percent of all reported cases [5]. 
Preventing syncope requires better understanding of the cardiovascular system’s 
responses to orthostatic challenges.  Although researchers have conducted research 
dealing with blood pressure, hormone levels, and fluid flows, information describing 
volume distributions and shifts within the body has been lacking.  Magnetic Resonance 
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Imaging (MRI) can provide insights to these missing pieces of the puzzle.  Applying 
orthostatic stress within a magnetic bore, however, can be a difficult task because of 
MRI’s limitations including space constraints, MR bore orientation, and exclusion of 
magnetic materials.  Lower Body Negative Pressure (LBNP) is one orthostatic stress 
that can be used within an MRI system. 
Lower Body Negative Pressure causes blood to pool in the lower extremities in a 
manner similar to the venous pooling that occurs prior to many syncopal episodes.  This 
orthostatic stress has been used to study cardiovascular regulation.  Despite the wealth 
of knowledge that has been accumulated through the use of this technique, few 
experiments have been conducted to determine fluid volume shifts in specific locations 
within the vascular system of the human body as a result of exposure to this stress.  
One important area is the venous side of the circulation because of its high compliance 
and because of its role in providing venous return during orthostatic stress.  The 
combination of MRI and LBNP provides a unique opportunity to non-invasively identify 
these changes beyond the capabilities of more global techniques such as impedance 
measurement and echocardiography. 
The objective of the present study was to determine, using MRI, changes in size 
and shape of the inferior vena cava as a result of the orthostatic stress imposed by 
LBNP.  Measurements were taken during supine control, LBNP-ramping, and steady-
state LBNP conditions.  The possible relative contributions of biomechanical responses 
(initial changes during and immediately after ramping LBNP) and regulatory responses 
(responses during the steady state period following ramping) were also investigated.
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2 Background 
 
2.1 Orthostatic Challenge 
Orthostatic challenge describes the resistance to blood flow from the lower 
extremities toward the heart.  The cardiovascular system regulates vascular pressure in 
order to maintain adequate blood flow.  As resistance to flow increases, pressure must 
increase proportionately in order to maintain constant flow. 
Equation 1 describes fluid flow as a function of pressure and resistance.   
                            Flow = Pressure / Resistance             (Eq. 1) 
Fluid pressure can be obtained from Equation 2.    
 
                                 P = P0 + ρgh               (Eq. 2) 
This formula can be applied to the cardiovascular system, where the second component 
(ρgh) describes the orthostatic challenge (ρ = volume density, g = gravitational 
acceleration, h = the vertical distance between the lower extremities and the heart). 
 
2.1.1 Orthostatic Stress 
Orthostatic stress causes redistribution of fluid within the body.  Blood volume 
shifts within the vasculature because of changes to transmural pressure, causing 
venous pooling in the lower extremities.  This pooling, in turn, reduces mean arterial 
blood pressure as well as the return of blood flow from the lower body to the heart [6].    
These reductions can lead to syncope, depending upon the individual’s ability to adapt 
to the challenge. 
 
2.1.2 Lower Body Negative Pressure 
Lower Body Negative Pressure (LBNP) describes the application of vacuum 
pressure outside the lower body, from the iliac crest of the hip down to the bottom of the 
feet (see Figure 2.1).  Reduction of pressure within the chamber causes a reduction in 
extravascular pressure, therefore causing an increase in transmural pressure.  Although 
orthostatic stresses induced by tilt and standing do not affect extravascular and 
transmural pressures in precisely the same way as LBNP, the adaptive mechanisms 
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triggered by LBNP are consistent with the body’s response to other orthostatic 
challenges [7,8].    
LBNP causes a decrease in central blood volume as fluid pools in the lower 
body, initially collecting in the venous side of the vasculature.  As venous structures in 
the lower body fill, the corresponding increase in hydrostatic pressure draws vascular 
fluid into the interstitial space [9].  The cardiovascular system therefore loses plasma 
volume, resulting in lower venous return to the heart.  This reduction in central blood 
volume causes cardiac output and stroke volume to decrease, compromising regulation 
of arterial blood pressure and blood flow [6].  The cardiovascular system’s 
compensation for these changes includes increases in heart rate and peripheral 
vascular resistance [10]. 
Besides being the only method for inducing the pooling of blood within the lower 
extremities in subjects in a zero gravity environment, LBNP provides a method for 
creating fluid shifts in a controlled manner on Earth.  When considering MR imaging, 
LBNP provides an optimal orthostatic stress for MRI studies because of physical 
constraints.  A standing or tilt test is not possible with closed, horizontal MR bore units.  
Thus, LBNP provides a means for applying a consistent, controllable orthostatic stress 
to subjects within the parameters imposed by the closed, horizontal bore of an MR unit. 
These LBNP studies served as a precursor to additional MRI investigations of the 
effects of six degree head-down bed rest upon the human cardiovascular system [see 
Figure 2.2].  Six degree head-down tilt provides one accepted tool for studying the 
effects of prolonged weightlessness on the cardiovascular system.  Together, these 
companion studies provided an extensive view of fluid distribution in the cardiovascular 
system during control, deconditioning (i.,e, head down bed rest), and application of a 
provocative stimulus (i.e., LBNP).  
 
2.2  Imaging Technology: Magnetic Resonance 
Magnetic Resonance Imaging provided an opportunity to visualize the fluid 
distribution within the cardiovascular system - as a function of orthostatic stress – with 
unprecedented resolution and clarity.  Some studies have attempted to calculate fluid 
distribution between whole body segments with impedance plethysmography but are 
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unable to discriminate between vascular and extravascular space, much less venous 
and arterial distributions [11, 12].  Some studies utilized ultrasound technology, but 
lacked the resolution and clarity that MR provides.  Magnetic Resonance offers the best 
combination of measurement accuracy, soft tissue contrast, and resolution compared to 
other non-invasive techniques for visualizing internal anatomy [13]. 
 
2.3 Scanning Planes 
MR images are mostly acquired within three fundamental planes: Axial, Coronal, 
and Sagittal.  Figure 2.3 illustrates the Axial and Coronal planes with respect to the MR 
bore [in which the human body typically lies supine].  The MR bore contains three 
gradient coils that alter magnetic field strength along each of the principal axes (X, Y, 
Z).  Manipulation of field strength along these axes creates gradients that establish the 
imaging planes.  The magnetic isocenter is the center point of the axes and the center 
of the bore.  Magnetic field strength never changes at this point, even during the 
application of gradients [14]. 
 
2.3.1 Axial 
Axial slices are selected by manipulating the Z gradient to alter field strength and 
precessional frequency along the magnet’s Z axis [14].  Axial planes are defined by the 
X- and Y-axes, as illustrated in Figure 2.3. 
 
2.3.2 Coronal 
Coronal slices are selected by manipulating the Y gradient to alter field strength 
and precessional frequency along the magnet’s Y axis [14].  Coronal planes are defined 
by the X- and Z-axes, as illustrated in Figure 2.3.  
 
2.3.3 Sagittal 
Sagittal slices are selected by manipulating the X gradient to alter field strength 
and precessional frequency along the magnet’s X axis [14].  Sagittal planes, not 
explicitly illustrated in Figure 2.3, are defined by the Y- and Z-axes.  
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2.3.4 Oblique 
Oblique slices are selected by using two gradients in combination [14]. 
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Figure 2.1: Lower Body Negative Pressure Chamber 
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Figure 2.2: Six Degree Head Down Bed Rest Setup in MR Chamber 
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Figure 2.3: Magnetic Resonance Imaging Planes 
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3 Methods 
 
3.1 Subjects 
Data were acquired from studies conducted over a two-year period at the 
University of Kentucky Clinical Research Center (UK CRC) and at the University of 
Kentucky Magnetic Resonance Imaging Spectroscopy Center (UK MRISC).  The 
complete subject pool consisted of ten healthy men (178.8 ± 1.8 cm, 77.6 ± 3.4 kg, 25.2 
± 1.0 yr) and ten healthy women (166.8 ± 2.7 cm, 70.9 ± 2.9 kg, 25.8 ± 1.2 yr).  All 
women’s menstrual periods were naturally cycling.  They were studied between days 
two and ten of their menstrual cycle.  Men were studied in the first year during a three-
month period, and women were studied during a three-month period in the second year. 
All volunteers were oriented to LBNP and to the MRI chamber at least one week 
prior to participation in the study.  Orientation also included screening for habits (e.g., 
smoking) and medical conditions (e.g., cardiovascular disease) that would have 
disqualified them from participation.  All subjects provided written consent to the test 
protocols approved by the local Institutional Review Board (IRB approval 91-00012). 
 
3.2 Study Protocol 
Table 3.1 outlines the experimental protocol used with each volunteer.  Note that 
with alternating subjects, the MRI studies preceded the CRC studies. 
 
3.3 MR Imaging Setup 
 
3.3.1 MRI Chamber 
The MRI system was a 1.5 Tesla Siemens system.  The MR bore was 60 
centimeters in diameter, making it wide enough to accommodate an LBNP chamber.  
The bore of the MR imager was easily long enough to contain an LBNP chamber since 
the MR bore was designed to fit human adults from head to toe. 
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3.3.2 LBNP Chamber 
The Lower Body Negative Pressure (LBNP) Chamber used in the MR imaging 
experiments was specially constructed from nonmagnetic materials such as different 
forms of plastic.  Because of the magnet’s strength, even small magnetic objects can 
become lethal projectiles; magnetic materials in the LBNP chamber could have also 
produced image artifacts.  These risks motivated the construction of the LBNP chamber 
with nonmagnetic materials.  The chamber’s size was also restricted to fit within the MRI 
chamber.  Consequently, the LBNP chamber used in the MRISC was 48 centimeters 
[19 inches] in diameter and 125.5 centimeters [50 inches] long.  By contrast, the 
standard LBNP chamber that was used in the CRC was 52.71 centimeters [21 inches in 
diameter] and 120.48 centimeters [48 inches long]. 
 
3.4 Imaging Sequences 
 
3.4.1 Time Of Flight  
Magnetic Resonance signals are sensitive to flow and to motion [15].  Hydrogen 
nuclei that move during image acquisition can create flow motion artifacts such as 
“phase ghosting” or “time of flight” displacement [14]. 
 In order to produce a spin echo MR signal, a nucleus must receive both an 
excitation pulse and a rephasing pulse.  In a spin echo sequence, if a nucleus only 
receives one of these two pulses, it does not produce an spin echo and hence no MR 
signal is received.  Stationary nuclei within the region of the excitation coil always 
receive both pulses, but moving nuclei might only receive the excitation pulse before 
moving through the targeted slice, thereby missing the rephasing pulse.  Other moving 
nuclei might lie outside the imaging plane during the excitation pulse but then enter the 
imaging plane in time to receive the rephasing pulse.  This condition in which nuclei 
receive one of the two pulses describes time of flight [14]. 
 The inflow and outflow of spins in a spin echo sequence result in variations in the 
amplitude of the signal due to the different history of RF pulses each spin receives 
during its transit of the image slice.  This effect is due strictly to the RF pulses and exists 
even in the absence of imaging gradients.  In addition to this effect, the amplitude of the 
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total signal is affected by the presence of imaging gradients.  To reduce the 
dependence of the signal on the velocity of motion, imaging sequences incorporate 
techniques known as gradient moment nulling and gradient moment rephasing.  
Additionally, by making the initial inversion pulse non-spatially selective (exciting the 
entire imaging region rather than a specific part of the imaging region such as the 
inferior vena cava), the effects of multiple pulses on the image wind up being relatively 
inconsequential.    
 One method of compensating for the effects of flowing nuclei on image quality, 
particularly in the case of venous blood flow, is the application of “gradient moment 
rephasing” which compensates for the altered phase values of nuclei flowing along a 
gradient.  By using additional gradients to force the altered phases back to their original 
values, the flowing nuclei do not change phase when exposed to the main gradient [14].  
Because these flowing nuclei have the same phase as stationary nuclei, their signals 
combine to create an even more intense, brighter signal within the slice [14].  Increased 
signal from fresh, previously unexcited nuclei flowing into the imaged region is known as 
“Inflow Signal Enhancement” [15]. 
The Time of Flight imaging sequences of this study utilized gradient moment 
rephasing to establish gray levels that were dependent upon Inflow Signal 
Enhancement.  Because of the cumulative effect of flowing nuclei, the highest velocity 
appeared as white and zero velocity appeared as black.  This technique was very useful 
for imaging vascular structures with laminar flow such as the inferior vena cava.  
Because image gray level correlated to velocity profile, the shape of the inferior vena 
cava itself could be captured due to the velocity profile of blood through that structure.  
Additionally, the initial inversion pulse was non-spatially selective, diminishing the 
effects of the multiple pulses on image clarity.    
In structures with laminar flow such as the inferior vena cava, fluid velocity is 
generally highest in the center and approaches zero at the vessel walls.  Velocity 
profiles may be parabolic or more blunt in shape, depending upon flow conditions.  A 
time of flight image of this vessel would appear brightest in the center and decrease in 
image brightness toward the vessel walls which would appear black, providing clear 
definition of the interior walls of the vessels, as illustrated in figure 3.3. 
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Although time of flight imaging can provide a very powerful tool for capturing the 
walls of venous structures, it does have limitations.  Subject motion during a time of 
flight scan can cause misregistration of the image.  Pulsatile flow of blood can also 
cause motion artifacts including blurring, making arterial structures such as the aorta 
more difficult to accurately capture [16]. 
 
3.4.2 Breath Holds 
Acquisition of images during breath holds reduces breathing-related artifacts 
such as ghosting, blurring, and misregistration [17].  Misregistration can still occur if the 
flow is oblique within the image plane.  It arises from the difference in time between the 
phase encoding and the frequency encoding gradients.  The purpose of capturing 
images during breath holds was to isolate the contributions of respiration from the 
effects of LBNP on changes in vena cava dimensions.  Images during end-inspiration 
and end-expiration were captured during steady-state –35 mmHg LBNP and during 0 
mmHg control. 
 
3.4.3 TurboFLASH 
TurboFLASH is a fast image acquisition technique that captures each image in 
less than two seconds.  Coupled with echogating (timing image acquisition to heart 
beat), this acquisition eliminates motion artifacts related to heart motion and lower 
frequency cycles such as breathing.  The reduced image resolution of this acquisition 
reduces edge definition, making it harder to identify vessel walls [14].  Despite its 
imprecision for edge detection, the speed of image acquisition made TurboFLASH a 
desirable technique for visualizing changes to the size and shape of the inferior vena 
cava as LBNP was ramped during the relatively brief span of one minute.  Figure 3.4 
illustrates an example of a TurboFLASH image of the inferior vena cava as it passes 
through the liver. 
 
3.5 Data Processing 
Images were analyzed with QuantIm image processing software by Zedec 
Technologies, Inc.  The raw images were transferred from the Siemens MRI system to a 
UNIX-based workstation that had been loaded with the software.  After loading an axial 
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or coronal image of the vena cava into the software package, the vena cava was 
separated from the rest of the image by using a variety of techniques.    
For example, in several time of flight images, venous branches that led into the 
vena cava had to be distinguished from the vena cava, requiring manual separation 
(segmentation) within the images.  Some time of flight images were affected by pulsatile 
blood flow in the aorta which caused the image of the aorta to smear, sometimes into 
the image of the vena cava; manual separation of the imaged vessels was necessary in 
these cases, too. 
Separation of the vena cava from the rest of the image was facilitated by 
manually drawing a boundary along the vessel edge.  The software’s “Segment” 
function then used gray levels to identify discrete structures.  Utilization of a Sobel filter 
enhanced the precision of vessel identification.  The Sobel filter improved the accuracy 
of edge detection by focusing on sharp changes and ignoring noise.  The Sobel filter, 
the sum of two convolutions, applied the algorithm in Equation 3. 
G0(x,y) = |Dxi(x,y)| + |Dyi(x,y)|                           (Eq. 3) 
Dxi was the gradient of the image in x, and Dyi was the gradient of the image in y [18]. 
Following user selection of the isolated vena cava, the software created an 
image contour map, selecting the outermost, continuous path of pixels corresponding to 
the vessel edge.  The contour map defined a Cartesian coordinate pair for each pixel.  
The Cartesian coordinate pairs were then used to measure cross sectional area, 
perimeter, maximum diameter, minimum diameter, angle of maximum diameter, and 
angle of minimum diameter. 
 Gray scale mapping was only used with the coronal images and with the purpose 
of enhancing the precision of vessel identification.  It required the user to draw a “profile 
line” across a region of interest.  The software then plotted gray levels of the image 
across the user-defined lined, as depicted in Figure 3.5.  The output of this function 
provided valuable information to the user for accurately and precisely defining the 
vessel edges. 
In order to compare volumes that were imaged before and during steady-state 
LBNP, the imaged regions had to be matched.  Axial vena cava images were matched 
by consistently targeting the region beginning at the tenth thoracic vertebra.  Matching 
 14
was also confirmed following image acquisition but prior to data processing by 
examining photographic films containing every slice in each data series.  By mounting 
this film onto a light box, multiple data sets could be compared side-by-side to confirm 
the presence of specific landmarks.  Axial slices of the vena cava were matched by a 
fixed, rigid coordinate system that was based on the tenth thoracic vertebra.  Although 
we always imaged a 3.6 cm length of the inferior vena cava beginning at the level of the 
tenth thoracic vertebra and progressing toward the level of the eleventh thoracic 
vertebra, we cannot guarantee that the 3.6 cm vena cava segment that was measured 
during control was the exact same 3.6 cm segment that was measured during –35 
mmHg LBNP.  The inferior vena cava could have shifted along the Z-axis as a result of 
LBNP, causing us to image a different segment of the inferior vena cava.  
In an attempt to ensure analysis of the same inferior vena cava segment under 
all conditions, coronal vena cava images were obtained from the same plane in fixed 
space.  This plane was selected by comparing several adjacent coronal images of the 
liver, seeking a slice that clearly showed the inferior vena cava traversing the liver from 
portal entry to portal exit.  Figure 3.7 shows four adjacent coronal slices across the liver.  
Slice B is the only one of these slices that includes a clear image of the inferior vena 
cava as it traverses the liver from portal entry to portal exit.  The physical space 
corresponding to this slice was then selected for obtaining eighteen coronal 
TurboFLASH images as LBNP was ramped from 0 to –35 mmHg (“LBNP ramp-up”) or 
from –35 to 0 mmHg (“LBNP ramp-down”).  This physical space was also imaged six 
times during the first minute of steady-state control and steady-state –35 mmHg LBNP.  
Because each subject went through two LBNP applications in the MR chamber, two 
sets of these data were available for each subject.  Review of the images, however, 
provided two complete sets for five male subjects but no complete sets for the female 
subjects.  For several female subjects, the inferior vena cava was not captured at all 
during LBNP ramp-up.  For the remaining female subjects, the inferior vena cava 
disappeared from the images before completion of LBNP ramp-up.  In the complete 
sets, the vena cava was visible throughout each ramping process and during the first 
minute of each steady-state condition (0 mmHg and –35 mmHg).   
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Table 3.1: Experimental Protocol 
Time Step 
7:00 PM 
Admit subject to UK CRC.  Fluid I/O begins.  Record subject height, weight, 
age, and calf circumference. 
9:00 PM Research staff leave floor nurses to begin monitoring subject activity. 
10:00 PM Check blood pressure, heart rate, and offer snacks. 
7:00 AM 
Awaken subject.  Apply intravenous (antecubital) catheter with heplock to 
subject’s right arm.  Walk around hospital. 
7:30 AM Subject eats a light, low fat, low protein breakfast. 
8:00 AM 
Subject lies in supine position.  Apply sensors for arterial pressure, thoracic 
impedance, ECG, Calf Circumference, radial artery flow, and skin flows. 
8:30 AM Begin recording 20 minutes of control data (subject is supine and resting). 
8:45 AM 
Draw 0.5 cc hematocrit blood samples in one-minute intervals for four 
minutes (2 cc).   
8:49 AM Draw hormonal blood samples (9 cc). 
8:50 AM 
End control and begin LBNP/LBPP (15 minutes each with an intervening 
five minute break) protocols (randomized by subject).  Draw hormonal 
blood samples during the final two minutes of LBNP (-35 mmHg) and 
during the final two minutes of LBPP (+15 mmHg).   
 
Continue drawing 0.5 cc hematocrit blood samples during LBNP and 
during the first five minutes of recovery following LBNP. (13.5 cc)  Continue 
drawing 0.5 cc hematocrit blood samples during LBPP and during the first 
five minutes of recovery following LBPP (13.5 + 2cc control).    
9:40 AM Complete first run.  Set up for echocardiogram studies. 
10:00 AM 
Begin recording ten minutes of echocardiography control data (e.g, End 
Diastolic Volume, End Stroke Volume). 
10:10 AM Begin fifteen minutes of LBNP. 
(continued on next page) 
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Table 3.1: Experimental Protocol (continued from previous page) 
Time Step 
10:25 AM End LBNP and begin five minutes of recovery. 
10:30 AM Subject ambulatory for light snack and transport to MRISC. 
11:00 AM Subject lies in supine position on MRI table. 
11:05 AM 
Apply sensors for LBNP, ECG, Arterial Pressure, temperature, PO2, and 
CO2. 
11:20 AM 
Acquire MRI anatomical images while repeating resting control, LBNP and 
LBPP protocols [without blood draws]. 
12:00 PM Change MRI parameters for perfusion and diffusion data collection. 
12:20 AM 
Acquire MRI perfusion and diffusion images while repeating resting control, 
LBNP and LBPP protocols [without blood draws]. 
1:00 PM Subject ambulatory for lunch.   
1:15 PM Check fluid balance and remove venous catheter. 
1:30 PM Dismiss subject. 
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Figure 3.1: (left) LBNP Chamber in MR Imager, View from Back of Magnet; (right) LBNP 
Chamber and Experimental Subject in MR Imager, View from Front of Magnet 
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Figure 3.2: Time of Flight Conceptual Drawing 
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Vena Cava 
Aorta 
Figure 3.3: Example of Time of Flight Image of Inferior Vena Cava 
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 IVC at Portal Exit 
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Figure 3.4: Example of TurboFLASH Image of Inferior Vena Cava  
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Figure 3.5: Gray Scale Mapping of the Inferior Vena Cava and Adjacent Tissue 
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Figure 3.6: Example of Matched Axial Vena Cava Images – A) Pre-LBNP, B) –35 
mmHg LBNP 
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Figure 3.7: Coronal, T1 Weighted Slices Across Liver Obtained to Identify the Inferior 
Vena Cava 
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4 Results 
 
4.1 Cross-sectional Area of Inferior Vena Cava 
For each subject, a 3.6 centimeter length of the Inferior Vena Cava (IVC) starting 
at the level of the tenth thoracic vertebra and proceeding toward the level of the 
eleventh thoracic vertebra was imaged as six consecutive, adjacent, non-overlapping 
0.6 centimeter axial slices.  This region was measured during steady state pre-LBNP [0 
mmHg] and during steady state LBNP [–35 mmHg].  During each steady state condition, 
the region was imaged twice: once during end inspiration breath hold and once during 
end expiration breath hold.  The Time-Of-Flight imaging sequence was utilized to 
acquire these images.  Assuming uniform cross-sectional area of the IVC within each 
slice, volume of the imaged region of the vessel was calculated by Equation 4. 
Volume = 0.6 Σ Areai                                  (Eq. 4) 
Four factor Analysis of Variance of the data identified which variables and 
interactions were significant.  The four factors in the model were  
1) Gender [male versus female],  
2) LBNP [0 mmHg versus –35 mmHg],  
3) Breath Hold [end inspiration versus end expiration], and  
4) Subject ID [1 through 20]. 
Gender (p < 0.0005), LBNP (p < 1.02211 x 10-9), and Subject ID (p < 3.30052 x 
10-9) were significant main factors.  Breath Hold (p < 0.395282) was not a significant 
main factor.  Although Gender and LBNP were individually significant, their interaction 
was not statistically significant (p < 0.695876). 
Although gender was a significant factor with the non-normalized data, it was no 
longer significant after normalization against body surface area (p < 0.19).  Body 
surface area was calculated by using the Mosteller Formula shown in Equation 5. 
Body Surface Area (m2) = ([Height(cm) x Weight(kg)]/3600)1/2            (Eq. 5) 
Figure 4.1illustrates the volume of the selected section of the IVC as a function of 
gender, LBNP, and respiration.  This graphical presentation of the data visually 
reinforces the statistical conclusions.  Comparisons between end inspiration and end 
expiration breath holds do not suggest any clear relationship between respiration and 
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volume of the inferior vena cava at the level of the tenth thoracic vertebra.  At 0 mmHg, 
IVC volume was two percent smaller during end inspiration than during end expiration; 
at –35 mmHg, IVC volume was 22% larger during end inspiration than during end 
expiration.  However, these differences were not statistically significant (p < 0.395).  
Because respiration was not a statistically significant factor, and because the interaction 
between respiration and LBNP was not statistically significant, the 22% difference in 
IVC volume between breath holds during –35 mmHg LBNP could not, for the purposes 
of this study, be used to represent a change that can be directly attributed to either 
respiration, LBNP, or their interaction. 
Although differences due to breathing were not statistically significant, the 
differences due to gender and LBNP were.  The breath hold data in Figure 4.1 were 
regrouped in order to generate the data in Figure 4.2.  For each combination of gender 
and LBNP (e.g., women at 0 mmHg, women at –35 mmHg, men at 0 mmHg, men at –
35 mmHg), the end expiration and end inspiration breath hold data were combined.  
Figure 4.2 illustrates the volume of the selected section of the inferior vena cava as a 
function of gender and LBNP but independent of respiration.   During control conditions 
(0 mmHg), women’s IVC volume was 17% smaller than men’s IVC volume.  During 
steady-state –35 mmHg LBNP, women’s IVC volume was 32% smaller than men’s IVC 
volume.  Men’s IVC volume decreased 36% from control to –35 mmHg LBNP; women’s 
inferior vena cava volume decreased 48% from control to –35 mmHg.  
 
4.2 Time History Changes in the Width of the Inferior Vena Cava 
In order to observe the immediate impact of LBNP on the inferior vena cava, 
eighteen coronal images of the IVC, where the IVC traversed the liver, were acquired 
over the minute that pressure was steadily ramped from 0 to –35 mmHg (“LBNP ramp-
up”).  Six more coronal images of the same IVC section were imaged during the first 
minute of steady state LBNP.  Similarly, eighteen coronal images of the IVC were 
acquired over the minute that pressure was steadily ramped from -35 to 0 mmHg 
(“LBNP ramp-down”); and six more images were acquired during the first minute of 
steady state recovery.  The TurboFLASH imaging sequence was utilized to acquire 
these images.  The width of the IVC was measured both where it entered the liver 
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(“portal entry”) and where it exited the liver (“portal exit”).  The descriptions “portal entry” 
and “portal exit” have been assigned with respect to the direction of blood flow in the 
inferior vena cava through the liver, toward the heart.  The resulting data is illustrated in 
Figure 4.3. 
 During control and recovery, vena cava width at portal exit (VCWexit) was 64.4% 
larger than vena cava width at portal entry (VCWentrance) (p < 0.0003).  As Figure 4.3 
clearly illustrates, VCWexit was always larger than VCWentrance.  LBNP ramp-up caused 
VCW to decrease at both measurement sites (p < 0.001).  From control to the end of 
LBNP ramp-up, VCWentrance decreased by 61.6% and VCWexit decreased by 45.8%.   
 During the first minute of steady-state –35 mmHg LBNP, both VCWentrance and 
VCWexit exhibited a “rebound” effect by increasing 13% and 21.2% of their original 
control values, respectively.  This moderate recovery was statistically significant (p < 
0.005).  Interestingly, neither measurement site appeared to continue recovering past 
the first minute of steady-state –35 mmHg LBNP; this observation is based on the 
negligible difference between each measurement site’s width one minute into steady-
state –35 mmHg LBNP and fourteen minutes into steady-state –35 mmHg LBNP.  
During LBNP ramp-down, both VCWentrance and VCWexit completed recovery toward their 
initial control values.   
The decreases in VCW at both measurement sites during LBNP ramp-up appear 
to be quadratic functions of time or LBNP (assuming the rate of change of LBNP was 
constant).  Figure 4.4 focuses on the LBNP ramp-up portion of the VCW data set.  The 
following relationships were obtained: 
For VCWentrance as a function of LBNP during ramp-up: 
VCWentrance = 0.0096(LBNP)2+0.6731(LBNP)+20.096, R2  = 0.9654         (Eq. 6) 
For VCWexit as a function of LBNP during ramp-up:  
VCWexit = 0.114(LBNP)2+0.7869(LBNP)+31.13, R2 = 0.9629                     (Eq. 7) 
Vena Cava Width changes at both measurement sites during the first minute of 
steady-state LBNP appear to be linear functions of time [but not of LBNP since it was 
held constant].  Figure 4.5 illustrates the steady-state –35 mmHg LBNP portion of the 
VCW data set.  The following relationships were obtained: 
For VCWentrance as a function of time during steady-state LBNP: 
 27
VCWentrance = 0.0592(time)+8.7172, R2  = 0.995                       (Eq. 8) 
For VCWexit as a function of time during steady-state LBNP: 
VCWexit = 0.0503(time)+18.117, R2 = 0.9712                       (Eq. 9). 
Vena Cava Width changes at both measurement sites during LBNP ramp-down 
appear to be linear functions of time or LBNP.  Figure 4.6 focuses on the LBNP ramp-
down portion of the VCW data set.  The following relationships were obtained: 
For VCWentrance as a function of LBNP during ramp-down: 
VCWentrance = 0.224(LBNP)+20.255, R2  = 0.9892                      (Eq. 10) 
For VCWexit as a function of LBNP during ramp-down: 
VCWexit = 0.2534(LBNP)+32.244, R2 = 0.9645                     (Eq. 11)  
The high R2 values for Equations 6 through 11 suggest that each equation provides a 
very good fit against the available data.   
Vena Cava Width changes at both measurement sites during the first minute of 
recovery do not appear to fit a linear or quadratic equation.  Changes during this period 
appear to be a combination of return to original control values along with some variation 
due to noise.  Figure 4.7 shows the recovery portion of the VCW data set.  The R2 
values corresponding to the equations for recovery are not as high as the R2 values 
corresponding to the other equations mentioned above, making the recovery equations 
tenuous approximations.
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Figure 4.1: Inferior Vena Cava Volume vs. Gender, LBNP, Respiration
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Figure 4.2: Inferior Vena Cava Volume vs. Gender, Lower Body Negative Pressure
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Figure 4.3: Vena Cava Width versus Lower Body Negative Pressure
0.00
5.00
10.00
15.00
20.00
25.00
30.00
35.00
40.00
0 10 20 30 40 50 60
V
C
W
 (m
m
)
Exit
Entrance
-35 mmHg
0 mmHgtime 1 2 16 17 18
n = 10
 
Figure 4.4: Vena Cava Width during Lower Body Negative Pressure Ramp-Up
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Figure 4.5: Vena Cava Width During First Minute Steady-State Lower Body Negative Pressure
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Figure 4.6: Vena Cava Width During Lower Body Negative Pressure Ramp-Down
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Figure 4.7: Vena Cava Width During First Minute Steady-State Recovery
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5 Discussion 
 
5.1 Volume of the Abdominal Inferior Vena Cava 
In the present study, the lack of a statistically significant relationship between 
breath holds and volume of the inferior vena cava at the entrance and exit of the liver 
appears to be inconsistent with existing knowledge of relationships between respiration 
and volume of the inferior vena cava.  An ultrasound study of 85 humans subjects 
observed partial collapse of the inferior vena cava during inspiration and maximum 
distension at end expiration [19].  A subsequent study of 14 human subjects measured 
inferior vena cava volume with an impedance catheter during normal, quiet respiration.  
This study noted that extrathoracic inferior vena cava volume rose with expiration while 
intrathoracic inferior vena cava volume decreased with expiration [20].  “Extrathoracic 
inferior vena cava” describes the region of the vena cava that lies below the diaphragm, 
and “intrathoracic inferior vena cava” refers to the region of the inferior vena that lies 
above the diaphragm.  Based on these earlier studies, volume of the abdominal inferior 
vena cava (i.e., below the diaphragm) should be at a minimum at end inspiration; at end 
expiration, the volume should be at a maximum. 
Even though the breath hold data from the present study was not statistically 
significant, an evaluation of the trends in the data may offer some additional insight.  
During control, volume of men’s inferior vena cava was 5.2% smaller at end expiration 
than at end inspiration.  During LBNP, the contrast was more substantial with a 
decrease of 27.4% from end inspiration to end expiration.  During LBNP, volume of 
women’s inferior vena cava decreased 2.7% from end inspiration to end expiration.  The 
expected contrast in volume of the inferior vena cava was apparent only in women 
during control when inferior vena cava volume was 12.5% larger at end expiration than 
at end inspiration. 
The reasons for the inconsistencies within data of the present study as well as 
between the present study and those of other studies are not clear.  The data could 
have been affected if subjects strained themselves during breath holds.  The length of 
time for every breath hold was constant across all subjects, but the ability to hold one’s 
breath varies from person to person.  Some subjects may have also found one breath 
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hold to be more difficult than the other.  Because some subjects may have struggled to 
maintain the breath holds, the data may have been affected by strain, thereby 
compromising the comparisons between breath holds.   
The inconsistencies could also be a result of tethering of the vessel walls to the 
surrounding tissue, making it less responsive to breathing than segments measured in 
other studies.  It appears that the other studies measured the effect of respiration on a 
different part of the inferior vena cava than the segment analyzed in the present study 
and, therefore, could have different tethering to their surrounding tissues. 
The inconsistencies could also be a result of differences in experimental 
protocols.  While the present study isolated end expiration and end inspiration by 
requiring test subjects to hold their breath, the other studies measured size of the 
inferior vena cava during normal, quiet respiration.  Perhaps response to the transient 
disturbance of normal breathing differs from response during steady-state breath holds.  
For example, just as the width of the inferior vena cava partially recovered during the 
first 60 seconds of steady-state LBNP following LBNP ramp-up, changes to inferior 
vena cava volume may have also recovered during steady-state breath holds following 
normal breathing.  
Inconsistencies during LBNP in the present study could be a consequence of the 
orthostatic stress itself.  The impact of LBNP upon the inferior vena cava could be so 
much more significant than the impact of respiration that it effectively masks variations 
due to breathing.  The difference in intrapleural pressure between end expiration and 
end inspiration is roughly 4 cm H2O or 2.9 mmHg [6].  Even though LBNP was directly 
applied to the body below the inferior vena cava (beginning at the iliac crest of the hip), 
its effect upon the inferior vena cava was both statistically and physiologically 
significant.  The –35 mmHg stress could very likely impact inferior vena cava volume far 
more than the 2.9 mmHg oscillation of respiration. 
While changes to inferior vena cava dimensions due to respiration appear 
unclear, the observed consistent and sizable volume decrease resulting from LBNP 
merits a key question: Was the impact of LBNP on vena cava size real, or was it an 
indication of vessel displacement along the Z-axis (stretching/compression, sliding)?  
Recall this study’s use of a rigid coordinate system, focusing on a fixed 3.6 cm space 
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rather than on a fixed 3.6 cm length of the inferior vena cava.  Consequently, movement 
by the vessel along the Z-axis was not captured by the images and therefore possibly 
influenced the accuracy of the data.   
On the other hand, if the inferior vena cava slid along the Z-axis during LBNP, it 
would have slid away from the heart, toward the abdomen.  Because the inferior vena 
cava gets wider as it approaches the heart, we would expect this displacement to be 
seen as an increase in axial cross-sectional area and in coronal width.  Although this 
certainly may have happened, the vessel’s tendency to collapse during LBNP was far 
more evident than any displacement that might have occurred.  Even if the vessel slid 
along the Z-axis, this movement does not decrease the significance of our observations 
regarding volume and width of the inferior vena cava.  Rather, the possibility of 
displacement could make the observed changes even more significant physiologically 
because a wider section closer to the heart during control would have had to slide along 
the Z-axis and collapse even more than the segment that was visualized during control. 
 
5.2 Inferior Vena Cava Width as a Function of Changes in LBNP 
The observed changes in inferior vena cava width at portal entry and at portal 
exit during all three phases of LBNP (ramp-up, steady-state, and ramp-down) 
supplement existing knowledge of cardiovascular response to orthostatic stress.  
Reductions in vena cava width at portal entry and at portal exit suggest that transmural 
pressure at both measurement sites dropped as a result of LBNP.  In order for 
transmural pressure to decrease, the intravascular pressure at these two measurement 
sites must have dropped because the body at the measurement sites was outside the 
LBNP chamber and was therefore at atmospheric pressure during the measurements.  
Indeed, in another study conducted in our laboratory, central venous pressure was 
measured during LBNP and revealed that central venous pressure in the thoracic region 
decreases as LBNP becomes more negative.  Figure 5.1 illustrates this relationship 
between central venous pressure and LBNP. 
Venous pooling in the lower extremities is a well-documented result of LBNP, 
and this response apparently does not extend up to the abdominal inferior vena cava.  A 
static region of the venous circulation must exist somewhere in between the collapsing 
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inferior vena cava and the distending veins of the lower extremities.  Presumably, no 
change in volume would be observed at this transition point.  One possible location for 
this transition point could be somewhere near the level of the iliac crest since that region 
marks the boundary between atmospheric pressure and negative pressure. 
The inferior vena cava’s response to all three phases of LBNP is most likely a 
result of four factors: 1) the vessel’s intrinsic mechanical properties (i.e., its basic 
material compliance), 2) its physical connections (i.e. tethering and anchoring of the 
vessel) to surrounding tissues, 3) physiological control of vessel width (e.g., 
vasodilation/vasoconstriction as a result of neural and/or hormonal mechanisms), and 4) 
fluid volume regulation by the cardiovascular system in response to the orthostatic 
stress.  Factors 2 and 3 when added to factor 1 produce an “effective compliance”.  
Factor 4 relates to the fact that the segment under examination is in a closed fluid circuit 
that can absorb or release fluid and therefore change intravascular pressure and fluid 
volume in response to orthostatic stress and associated neurally mediated 
responses[21].  The change in intravascular pressure can also contribute to change in 
transmural pressure, resulting in change to vessel width. 
Therefore, in the present study, all four factors could be responsible for observed 
differences in vena cava response at portal entry and at portal exit: 1) the material 
compliance of the inferior vena cava at the portal exit could be higher than at portal 
entry; 2) the effective compliance at the portal exit could be higher than at portal entry 
because of tissue surrounding, tethering, and anchoring the vessel and/or because of 
vasoconstriction/vasodilation; 3) a change in the blood pressure gradient could have 
occurred along the length of the inferior vena cava due to changes of fluid moving into 
the circulation in response to the onset of LBNP.   
For example, the inferior vena cava exhibited a partial recovery during the first 
minute of steady-state LBNP.  Further recovery was not apparent at the next data point 
fourteen minutes later.  An increase in plasma volume in response to the first two 
minutes of –35 mmHg LBNP has previously been reported and is thought to be a direct 
result of sympathetically mediated vasoconstriction in response to LBNP [21, 22].  The 
inferior vena cava completely recovered back to its control widths by the end of LBNP 
ramp-down.  The absence of hysteresis when comparing inferior vena cava width during 
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control and during recovery suggests that there were no relatively long-term residual 
changes such as creep or relaxation of the vessel’s mechanical properties or sustained 
vasoconstriction or vasodilation after the exposure to LBNP.   
Recall that the vessel’s response to LBNP ramp-up was a quadratic equation 
according to Equations 6 and 7.  The partial recovery during steady-state LBNP was a 
linear equation per Equations 8 and 9.  The completion of recovery during LBNP ramp-
up was a linear equation documented by equations 10 and 11.  Thus, recovery during 
steady-state LBNP could reflect some combination of the vessel’s material compliance 
with cardiovascular regulation (i.e., vasodilation).  Recovery during LBNP ramp-down 
appears to correspond to the inferior vena cava’s effective compliance and perhaps to 
regulation as well.  The inferior vena cava recovered from LBNP ramp-up as much as 
its material compliance allowed while still subjected to a constant –35 mmHg stress.  As 
the –35 mmHg stress diminished toward zero mmHg during LBNP ramp-down, the 
vessel continued toward its control widths at both measurement sites in a linear fashion, 
dependent upon the level of LBNP stress.  There appears to be a change to the relative 
contributions of the inferior vena cava’s four response factors as LBNP progressed from 
ramp-up to steady-state and on to ramp-down.  While the vessel returned to its control 
state, the combination of factors dictating its response during LBNP ramp-up appeared 
to differ from the combination of factors dictating its response during steady-state LBNP 
and during LBNP ramp-up. 
As vessel width increased at both measurement sites during steady-state LBNP, 
presumably the intravascular pressure at each site also increased.  If the change in 
intravascular pressure during the first minute of steady-state LBNP (dP/dt) was known, 
the slopes of equations 7 and 8 (change in width per change in time, dW/dt) could be 
divided by the equivalent change in intravascular pressure to identify the material 
compliance at each site.  This method for calculating material compliance of the inferior 
vena cava at each site is represented by Equation 12. 
Material Compliance = [dW/dt] * [dP/dt]-1                     (Eq. 12)   
The inferior vena cava’s effective compliance can be calculated by using the 
relationship between LBNP and central venous pressure illustrated in Figure 5.3.  The 
slopes of equations 10 and 11 (change in width per change in LBNP, dW/dPLBNP) can 
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be divided by the equivalent change in central venous pressure to identify the effective 
compliance at each site.  This method for calculating effective compliance of the inferior 
vena cava at each site is represented by Equation 13. 
Effective Compliance = [dW/ dPLBNP] * [dPCV/ dPLBNP]-1                   (Eq. 13) 
Assuming that the rate of LBNP ramp-down was linear, the result of Equation 13 should 
match the slopes of Equations 10 and 11. 
While all of the interrelationships amongst the possible mechanisms discussed 
above could have changed from LBNP ramp-up to steady-state LBNP and on to LBNP 
ramp-down, the specific relative contributions of each factor to the measured response 
of the inferior vena cava is beyond the scope of the present study.   
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Figure 5.1: Central Venous Pressure vs. Lower Body Negative Pressure
 
 
 
6 Conclusions 
Data from this study did not reveal any differences in size of the inferior vena 
cava between end inspiration and end expiration breath holds in either gender during 
control and during –35 mmHg LBNP.  However, the effects of –35 mmHg lower body 
negative pressure upon axial cross-sectional area and coronal width of the inferior vena 
cava were statistically and physiologically important.  The present study provided the 
following major findings: 
1) IVC volume for men and women combined decreased 41% due to LBNP (p < 
1.02 x 10-9); 
2) women’s gross IVC volume was 23% smaller than men’s during control and 
LBNP (p < 0.0005); however, normalization against body surface area eliminated 
statistical significance of this difference; 
3) the IVC volume change caused by LBNP was not statistically different between 
genders (p < 0. 696); 
4) respiration had no statistically significant impact on IVC volume (p < 0.395); 
5) men’s IVC width was 64.4% wider at portal exit than at portal entry (p < 0.0003); 
6) –35 mmHg LBNP induced a decrease in men’s vena cava width up to 46% at 
portal exit and up to 62% at portal entry. 
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